Experimental ischemic heart disease--effects of synthetic thromboxane A2. 1979

S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D011463 Prostaglandins H A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
January 1987, Sovetskaia meditsina,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
March 1981, Prostaglandins and medicine,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
January 1983, Advances in prostaglandin, thromboxane, and leukotriene research,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
July 1981, The New England journal of medicine,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
March 1981, Prostaglandins,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
January 1982, Journal of cardiovascular pharmacology,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
June 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
S Morooka, and M Kobayashi, and T Takahashi, and Y Takashima, and M Sakamoto, and T Shimamoto
August 1997, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!